A hypothesis-generating analysis on the role of TERT promoter mutation in advanced #UrothelialCarcinoma treated with immunotherapy. #BeyondTheAbstract with veronica mollica, Paola Valeria Marchese, MD, and Francesco Massari > bit.ly/3hUEGgS

Which role of TERT promoter mutation in advanced #UrothelialCarcinoma ? Our experience at Università di Bologna with Paola Valeria and veronica mollica

Toni Choueiri, MD And this is our comment with my precious colleague veronica mollica

Proud of my colleague veronica mollica a rising star of Genitourinary Oncology. This is our comment just published on The Lancet Oncology Toni Choueiri, MD Belzutifan: enhancing the blockade of angiogenesis in renal cell carcinoma sciencedirect.com/science/articl…

NOW OF: In a US, single-arm, ph 2 trial of pts w/ adv clear cell renal cell carcinoma previously treated with immunotherapy, 16 (30·8% [95% CI 18·7–45·1]) of 52 pts had an OR with belzutifan plus cabozantinib (median FU 24·6 months [IQR 22·1–32·2]). thelancet.com/journals/lanon…

"Given its ambitious target and a plethora of promising preliminary evidence in support, belzutifan is a strong candidate to open a new therapeutic field." Linked Comment by Veronica Mollica and Francesco Massari thelancet.com/journals/lanon…

🌟HOT OFF THE PRESS FOR AACR #AACR23 with MCW Cancer Center Razelle Kurzrock, MD veronica mollica Francesco Massari in Pharmaceuticals MDPI🌟 "Getting the Right Drug💊to the Right👱‍♀️Patient👨‍🦳with the Right Genomics🧬‼️ bit.ly/3GTRZI4

The Ever-changing pathologic classification of RCC. Out now on European Urology our Words of Wisdom with Valentina Tateo and veronica mollica authors.elsevier.com/a/1h34K14kplv9…

⚡️Just out at Critical Reviews in Oncology Hematology (CROH) the 1st systematic review and NMA with immune-combos in 1st line mUC (including the data of EV-302 just published). sciencedirect.com/science/articl… Andrey Soares Francesco Massari veronica mollica Maite Bourlon Shilpa Gupta Andre Sasse André Paternò Castello Dias Carneiro

Tumor growth rate and treatment in renal cell carcinoma. From the past at Gustave Roussy with Roberto Iacovelli and Prof. Bernard Escudier to the present se Università di Bologna with veronica mollica A never ending story..

A rising star in #genitourinary #oncology today is PhD at Università di Bologna Proud of you veronica mollica

What could be the right treatment for papillary #rcc? Ongoing clinical trials will give an answer. Now I am proud to present our global experience just published on European Urology Oncology Thanks to MatteSantoni all ARON Team! Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Uromigos European Association of Urology (EAU) AIOM SIUrO

EAU YAU RCC working group #social #dinner in Paris #EAU24 🇫🇷 Carlotta Palumbo Riccardo Campi 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD Daniele Amparore Savio Domenico Pandolfo Selcuk Erdem Michele Marchioni veronica mollica Angela Pecoraro Stijn Muselaers Leonardo D. Borregales, MD

Stellar presentation by veronica mollica at #EAU24 about ARON-1 global real life of the treatment of papillary #mrcc Proud for the merit for best presentation. Thanks to all Aron Team

And so.. this is the story of the #RCC adjuvant treatment Toni Choueiri, MD Tom Powles

Out now our Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy. Another result by the ARON Team joaquim bellmunt Marco Maruzzo Enrique Grande Roberto Iacovelli Patrizia Giannatempo Giuseppe Procopio Fernando Sabino, MD, PhD

Out now on ESMO Open our research supported by the Italian Ministry of Health conducted with prof. Stefano Fanti and veronica mollica about the early evaluation of response to ARTA in mCRPC with PET and different radiotracers  ESMO - Eur. Oncology UROweb OncoAlert

⚠️📢 Out now on Nature Reviews Urology our comment about the role of adjuvant immunotherapy in #rcc Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Tom Powles AIOM Uromigos OncoAlert

🔴Just out one more piece of ARON international collaborative group. RWE showing the efficacy of Pembrolizumab in 2nd line treatment for mUTUC. Francesco Massari Andrey Soares Javier Molina Cerrillo veronica mollica Deniz TURAL #ARONTeam link.springer.com/article/10.100…

Impressive work for an important collaboration